Leask, A., Xu, S., Renzoni, E., Bou-Gharios, G., du Bois, R., Abraham, D., & Black, C. (2005). Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रLeask, A., S. Xu, E. Renzoni, G. Bou-Gharios, R. du Bois, D. Abraham, और C. Black. Bosentan Alleviates the Pro-fibrotic Phenotype of Lung Scleroderma Fibroblasts: Implications for Treatment of Scleroderma. 2005.
एमएलए (9वां संस्करण) प्रशस्ति पत्रLeask, A., et al. Bosentan Alleviates the Pro-fibrotic Phenotype of Lung Scleroderma Fibroblasts: Implications for Treatment of Scleroderma. 2005.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.